Positron emission tomography at the end of first-line therapy and during follow-up in patients with Hodgkin lymphoma: a retrospective study

Revised Response Criteria for Malignant Lymphoma

Bruce D. Cheson, Beate Pfistner, Malik E. Juweid et al. · Journal of Clinical Oncology · 2007 · 4.4K citations · Full text

Medicine, Oncology, Pathology +15

Thoracic positron emission tomography using18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease

Martin R. Weihrauch, Daniel Ré, Klemens Scheidhauer et al. · Blood · 2001 · 233 citations · Full text

Medicine, Nuclear Medicine, Radiology +14

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

Guy Jérusalem, Yves Béguin, Marie France Fassotte et al. · Annals of Oncology · 2002 · 215 citations

Medicine, Oncology, Radiology +15

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

Carsten Kobe, Markus Dietlein, Jeremy Franklin et al. · Blood · 2008 · 204 citations · Full text

Medicine, Oncology, Radiology +17

Role of [¹⁸F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma

Pier Luigi Zinzani, Vittorio Stefoni, Monica Tani et al. · Journal of Clinical Oncology · 2009 · 166 citations

Medicine, Nuclear Medicine, Oncology +15